欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/2395/001
药品名称Bortezomib Actavis
活性成分
    • BORTEZOMIB 3.5 mg
剂型Powder for solution for injection
上市许可持有人Actavis Group PTC ehf. Dalshraun 1 220 Hafnarfjörður Iceland
参考成员国 - 产品名称Denmark (DK)
Bortezomib Actavis
互认成员国 - 产品名称
    • Iceland (IS)
      Bortezomib Actavis 3,5 mg Stungulyfsstofn, lausn
    • Hungary (HU)
      BORTEZOMIB ACTAVIS 3,5 mg por oldatos injekcióhoz
    • Romania (RO)
      Bortezomib Actavis 3,5 mg pulbere pentru solutie injectabila
    • Bulgaria (BG)
      Bortezomib Actavis
    • Slovenia (SI)
    • Croatia (HR)
许可日期2015/05/27
最近更新日期2024/06/04
药物ATC编码
    • L01XX32 bortezomib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase